GNMX
Aevi Genomic Medicine Inc
GNMX
GNMX
Delisted
GNMX was delisted on the 3rd of February, 2020.
38 hedge funds and large institutions have $8.64M invested in Aevi Genomic Medicine Inc in 2018 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 10 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
75% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 8
Holders
38
Holding in Top 10
1
Calls
$4K
Puts
–
Top Buyers
| 1 | +$40.3K | |
| 2 | +$25.5K | |
| 3 | +$24.4K | |
| 4 |
Jane Street
New York
|
+$13.5K |
| 5 |
Morgan Stanley
New York
|
+$3.7K |
Top Sellers
| 1 | -$291K | |
| 2 | -$61.4K | |
| 3 | -$45K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$45K |
| 5 |
Goldman Sachs
New York
|
-$38K |